OrthoPediatrics (KIDS) Q2 Revenue Up 16%
OrthoPediatrics (NASDAQ:KIDS), a specialist in pediatric orthopedic medical devices, reported its financial results for the second quarter on August 5, 2025. OrthoPediatrics reported GAAP revenue of $61.1 million in the second quarter but slightly below Wall Street’s $61.47 million GAAP estimate. The adjusted loss per share (Non-GAAP) narrowed to ($0.11), beating analyst expectations by $0.18 (non-GAAP). Year-over-year growth persisted across core segments, though higher operating expenses kept the company in a net loss position. Overall, the first quarter demonstrated strong revenue expansion, improving operational efficiency, and continued margin initiatives, even as investments in growth limited bottom-line progress.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
OrthoPediatrics is uniquely focused on designing and marketing orthopedic devices specifically for children. Its suite spans trauma and deformity correction products, scoliosis (spinal curvature) solutions, and sports medicine devices. This specialized approach addresses a market gap where adult devices are often less suitable for pediatric use, aiming to improve outcomes for young patients.
Source Fool.com
